GemCyclo Bio

Leading the Era of Oral Cyclic Peptides

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2025
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2025
Headcount
5
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

GemCyclo Bio is an early-stage bio-pharmaceutical company holding a library of novel orally available cyclic peptides targeting validated molecular pathways of immune and inflammatory diseases (I&I), Cancer, and metabolic diseases.

The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed and synthesized by Prof Chaim Gilon and his colleagues with the proprietary Cycloscan technology, rapidly achieving orally available small cyclic peptides which are highly potent and metabolically stable, enabling multiple routes of administration.

The novel GemCyclo Bio cyclic peptides embrace the best of small molecules and of larger protein drugs; they are easy to synthesize and of low immunogenicity as small molecules, and of highest affinity and selectivity to target active site as monoclonal antibodies (mAbs), and low off-target toxicity, all at the same time in one novel cyclic peptide molecule.

Q&A

When was GemCyclo Bio founded?
GemCyclo Bio was founded in March 2025.
What is GemCyclo Bio's primary focus?
GemCyclo Bio is an early-stage biopharmaceutical company focused on developing orally available cyclic peptides for immune and inflammatory diseases, cancer, and metabolic diseases.
What is the source of GemCyclo Bio's innovative drugs?
The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed using the proprietary Cycloscan technology by Prof Chaim Gilon and his colleagues.
How many employees does GemCyclo Bio currently have?
GemCyclo Bio currently has 1-10 employees.
Who are the co-founders of GemCyclo Bio?
The co-founders of GemCyclo Bio are Doron Friedman and Oron Yacoby - Zeevi.
What is the current stage of GemCyclo Bio's product development?
GemCyclo Bio's product development is currently in the R&D stage.
What is GemCyclo Bio's current funding stage?
GemCyclo Bio is currently in the Pre-Funding stage.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

drug-discoveryautoimmune-diseasesinflammatory-diseasesmetabolic-diseasepeptidescancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)